What are the side effects of dabrafenib?

Dabrafenib is a targeted therapy drug used to treat advanced or metastatic malignant melanoma (melanoma), non-small cell lung cancer and other cancers carrying BRAF V600 mutations. Although dabrafenib has achieved remarkable results in treating cancer, patients may experience some side effects during use. The following are possible side effects of dabrafenib:

1.Skin reaction:

Skin rash: One of the most common side effects of dabrafenib is a mild to moderate rash that may be itchy or dry. This rash may appear within weeks of starting treatment and may affect the patient's quality of life.

Dryness and flaking: Patients may experience symptoms of dryness and flaking of the skin, especially on the hands and feet.

Photosensitivity: Dabrafenib may make patients more sensitive to sunlight, increasing the risk of sunburn and tanning.

Fever:

Dabrafenib may cause fever, which may be due to the body's immune response to the drug. Patients should closely monitor body temperature changes while taking dabrafenib and report to their doctor in a timely manner.

2.Fatigue: Patients may feel tired or weak during treatment. This fatigue may affect a patient's ability to perform daily activities and quality of life.

3.Headache: During dabrafenib treatment, patients may experience symptoms of headache or dizziness. This may be due to the drug's effects on the central nervous system.

4.Nausea and vomiting: Dabrafenib may cause nausea and vomiting, which may affect the patient's appetite and nutritional intake.

5.Arthralgia and Myalgia: Dabrafenib may cause symptoms of arthralgia and myalgia, which may affect a patient's mobility and quality of life.

6.Visual problems: Dabrafenib may cause visual problems, such as blurred vision or a feeling of dry eyes. Patients should seek medical attention promptly when these symptoms occur.

7.Heart problems: Dabrafenib may affect heart function, leading to heart problems such as arrhythmia or heart failure. Patients should receive regular cardiac monitoring and evaluation during treatment.

8.Abnormal liver function: Dabrafenib may cause abnormal liver function, including symptoms such as elevated liver enzymes and jaundice. Patients should undergo regular liver function monitoring during treatment.

9.Bleeding tendency: Dabrafenib may increase the patient's risk of bleeding, including skin bleeding, nose bleeding, and gastrointestinal bleeding. Patients should take care to avoid injury and avoid medications that may increase the risk of bleeding.

The side effects listed above may not occur in all patients, and their severity and duration may vary on an individual basis. Patients should pay close attention to changes in their symptoms while taking dabrafenib and report to their doctors in a timely manner. Doctors will adjust the treatment plan according to the patient's specific conditions to minimize the occurrence of side effects and ensure the safety and effectiveness of the treatment.